Trial intelligence / Profile preview

T-817MA Combination Rehabilitation and AMPA Receptor Changes by [11C]K-2 PET After Stroke

jRCTs031220728Completed

Sponsor
Takeda Science Foundation Japan Society For The Promotion of Science
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Trial of edonerpic in hemiparesis, ischemic stroke and intracerebral hemorrhage (ICH) (2 arms), sponsored by Takeda Science Foundation Japan Society For The Promotion of Science. Primary endpoint: Change in AMPA receptor binding per brain voxel. Started Apr 2023; status: completed.

02

Drugs

edonerpic
03

Conditions

hemiparesisischemic strokeintracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on jRCTs031220728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031220728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call